Pyrrolidine → HCID 24856991, compound
Reaction equation
CO[C:3](=[O:12])[C:4]1[CH:9]=[C:8](Br)[C:7](Cl)=[N:6][CH:5]=1.[NH:13]1[CH2:17][CH2:16][CH2:15][CH2:14]1.[CH3:18][O:19][C:20]1[CH:21]=[C:22](B(O)O)[CH:23]=[CH:24][CH:25]=1.[NH2:29][C@@H:30]([CH2:35][OH:36])[CH2:31][CH:32]([CH3:34])[CH3:33]>>[OH:36][CH2:35][C@H:30]([NH:29][C:3](=[O:12])[C:4]1[CH:9]=[C:8]([C:24]2[CH:23]=[CH:22][CH:21]=[C:20]([O:19][CH3:18])[CH:25]=2)[C:7]([N:13]2[CH2:17][CH2:16][CH2:15][CH2:14]2)=[N:6][CH:5]=1)[CH2:31][CH:32]([CH3:34])[CH3:33]Participants
5
Procedure
The title compound was synthesized in analogy to the procedure described for the preparation of Example 43, using 5-bromo-6-chloro-nicotinic acid methyl ester, pyrrolidine (commercially available), 3-methoxyphenyl-boronic acid (commercially available) and (R)-(−)-leucinol (commercially available) as starting materials. MS (ISP): 398.3 (M+H+).
Workup
- customdescribed for the preparation of Example 43
Sources & evidence
- ORD record
- ord-f30f24032cdd45388d1974cf7db9ca49
- Source dataset
- uspto-grants-2012_05
- Patent number
- US08188093B2
Reaction notes
Loading…